Beta (β)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendrocrine cells

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 5, 2000, Pages 579-585

  Anthony, ^a   Sim, ^a   Guillaume, ^b   Strosberg, ^b   Dhillon, ^a   Pounder, ^a   Wakefield, ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; PEPTIDE; POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN 18; UNCLASSIFIED DRUG;

ARTICLE; CHO CELL; DUODENUM; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROSECRETORY CELL; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT;

ANIMALS; ANTIBODIES; CHO CELLS; CRICETINAE; DUODENUM; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MUSCLE, SMOOTH; RABBITS; RECEPTORS, ADRENERGIC, BETA; SOMATOSTATIN;

EID: 0034057190     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00722.x     Document Type: Article

References (21)

1. 3-adrenoceptor. Science 1989; 245: 1118-21.
2. 3-adrenoceptor. Ann Rev Pharmacol Toxicol 1997; 37: 421-50.
3. 3 Arch JRS, Ainsworth AT, Cawtborne MA, et al. Atypical β-adrenoceptors on brown adipocytes as target for anti-obesity drugs. Nature 1984; 309: 163-5.
4. 4 MacDonald A, Forbes IJ, Gallacher D, et al. Adrenoceptors mediating relaxation to catecholamines in rat isolated jejunum. Br J Pharmacol 1994; 112: 576-8.
5. 5 Bianchetti A, Manara L. In vitro inhibition of intestinal motilily by phenylethanolaminotetralines: evidence of atypical β-adrenoceptors in rat colon. Br J Pharmacol 1990; 100: 831-9.
6. 3-adrenoceptors. Br J Pharmacol 1995; 116: 1945-7.
7. 7 Koike K, Horinouchi T, Takayanagi I. Possible mechanisms of β-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig Taenia caecum. Eur J Pharmacol 1995; 279: 159-63.
8. 3-selective adrenoceptor antagonist, SR 59230A. Br J Pharmacol 1996; 117: 1374-6.
9. 3-adrenergic receptor. Eur J Biochem 1995; 224: 761-70.
10. 3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 1998; 12: 519-23.
11. 3-adrenoceptor agonist in rat villi. Aliment Pharmacol Ther 1998; 12: 1121-9.
12. 12 Caroll MJ, Lister CA, Sennit MV, et al. Improved glycaemic control in C57B1/KsJ (db/db) mice after treatment with the thermogenic β-adrenoceptor agonist BRL268 30A. Diabetes 1985; 24: 1198-203.
13. 3-adrenoceptor agonist induces increased pancreatic blood flow and insulin secretion in rats. Eur J Pharmacol 1996; 298: 287-92.
14. 3-adrenoceptor stimulating gastrin and somatostatin secretions in rat antrum. Am J Physiol 1997; 272: G1000-6.
15. 15 Sjölund K, Sanden G, Hå Sundler F. Endocrine cells in human intestine; An immunocytochemical study. Gastroenterology 1983; 85: 1120-30.
16. 3-adrenoceptor agonist CL316243 prevents indomethacin-induced jejunal ulceration in the rat by reversing early villous shortening. J Pathol 1996; 179: 340-6.
17. 3-adrenoceptor in vitro with their gastroprotective effects in the concious rat. Br J Pharmacol 1996; 117: 580-6.
18. 3-adrenoceptor agonists - future drugs for the gastrointestinal tract? Aliment Pharmacol Ther 1996; 10: 859-63.
19. 19 Karmeli F, Eliakim R, Okon E, et al. Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats. Dig Dis Sci 1994; 39: 617-25.
20. 20 Kusterer K, Bucheit K-H, Schade A, et al. The somatostatin analogue octreotide protects against ethanol-induced microcirculatory stasis and elevated vascular permeability in rat gastric mucosa. Eur J Pharmacol 1994; 259: 265-71.
21. 21 Scheiman JM, Tillner A, Pohl T, et al. Reduction of non-steroidal drug-induced injury and leucocyte endothelial adhesion by octeotride. Gut 1997; 40: 720-5.